139 related articles for article (PubMed ID: 25845528)
41. DNA methylation and detection of cervical cancer and precancerous lesions using molecular methods.
Mersakova S; Nachajova M; Szepe P; Kasajova PS; Halasova E
Tumour Biol; 2016 Jan; 37(1):23-7. PubMed ID: 26459314
[TBL] [Abstract][Full Text] [Related]
42. MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer.
Zheng G; Li N; Jia X; Peng C; Luo L; Deng Y; Yin J; Song Y; Liu H; Lu M; Zhang Z; Gu Y; He Z
J Mol Med (Berl); 2016 Oct; 94(10):1129-1141. PubMed ID: 27055844
[TBL] [Abstract][Full Text] [Related]
43. Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.
Nowacki S; Skowron M; Oberthuer A; Fagin A; Voth H; Brors B; Westermann F; Eggert A; Hero B; Berthold F; Fischer M
Oncogene; 2008 May; 27(23):3329-38. PubMed ID: 18084322
[TBL] [Abstract][Full Text] [Related]
44. Quantitative analysis of the relationship between microRNA‑124a, -34b and -203 gene methylation and cervical oncogenesis.
Botezatu A; Goia-Rusanu CD; Iancu IV; Huica I; Plesa A; Socolov D; Ungureanu C; Anton G
Mol Med Rep; 2011; 4(1):121-8. PubMed ID: 21461574
[TBL] [Abstract][Full Text] [Related]
45. Human papilloma virus (HPV) E7-mediated attenuation of retinoblastoma (Rb) induces hPygopus2 expression via Elf-1 in cervical cancer.
Tzenov YR; Andrews PG; Voisey K; Popadiuk P; Xiong J; Popadiuk C; Kao KR
Mol Cancer Res; 2013 Jan; 11(1):19-30. PubMed ID: 23284001
[TBL] [Abstract][Full Text] [Related]
46. Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer.
Milutin Gašperov N; Sabol I; Planinić P; Grubišić G; Fistonić I; Ćorušić A; Grce M
PLoS One; 2015; 10(6):e0129452. PubMed ID: 26057381
[TBL] [Abstract][Full Text] [Related]
47. Cell adhesion molecule-1 (CADM1) expressed on adult T-cell leukemia/lymphoma cells is not involved in the interaction with macrophages.
Komohara Y; Ma C; Yano H; Pan C; Horlad H; Saito Y; Ohnishi K; Fujiwara Y; Okuno Y; Nosaka K; Shimosaki S; Morishita K; Matsuoka M; Wakayama T; Takeya M
J Clin Exp Hematop; 2017 Jul; 57(1):15-20. PubMed ID: 28420814
[TBL] [Abstract][Full Text] [Related]
48. miR-375 Modulates Radiosensitivity of HR-HPV-Positive Cervical Cancer Cells by Targeting UBE3A through the p53 Pathway.
Song L; Liu S; Zeng S; Zhang L; Li X
Med Sci Monit; 2015 Jul; 21():2210-7. PubMed ID: 26224081
[TBL] [Abstract][Full Text] [Related]
49. Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines.
Lee J; Yoon YS; Chung JH
Gynecol Oncol; 2008 May; 109(2):270-4. PubMed ID: 18377964
[TBL] [Abstract][Full Text] [Related]
50. [Correlation between Methylation of SALL3 and Cervical Cancer].
Zhao J; Wei X; Yang T; Zhao MY; Pei ML; Yang XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):609-614. PubMed ID: 31699190
[TBL] [Abstract][Full Text] [Related]
51. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
[TBL] [Abstract][Full Text] [Related]
52. Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia.
Ding DC; Chiang MH; Lai HC; Hsiung CA; Hsieh CY; Chu TY
Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):215-20. PubMed ID: 19819061
[TBL] [Abstract][Full Text] [Related]
53. Plasma CADM1 promoter hypermethylation and D-dimer as novel metastasis predictors of cervical cancer.
Rong G; Zhang M; Xia W; Li D; Miao J; Wang H
J Obstet Gynaecol Res; 2019 Jul; 45(7):1251-1259. PubMed ID: 30945386
[TBL] [Abstract][Full Text] [Related]
54. Differential expression of Oct4 in HPV-positive and HPV-negative cervical cancer cells is not regulated by DNA methyltransferase 3A.
Liu D; Zhou P; Zhang L; Wu G; Zheng Y; He F
Tumour Biol; 2011 Oct; 32(5):941-50. PubMed ID: 21674242
[TBL] [Abstract][Full Text] [Related]
55. UHRF1 epigenetically down-regulates UbcH8 to inhibit apoptosis in cervical cancer cells.
Zhang Q; Qiao L; Wang X; Ding C; Chen JJ
Cell Cycle; 2018; 17(3):300-308. PubMed ID: 29157076
[TBL] [Abstract][Full Text] [Related]
56. Expression of a splicing variant of the CADM1 specific to small cell lung cancer.
Kikuchi S; Iwai M; Sakurai-Yageta M; Tsuboi Y; Ito T; Maruyama T; Tsuda H; Kanai Y; Onizuka M; Sato Y; Murakami Y
Cancer Sci; 2012 Jun; 103(6):1051-7. PubMed ID: 22429880
[TBL] [Abstract][Full Text] [Related]
57. Re-expression of cell adhesion molecule inhibits growth and induces apoptosis of human pancreatic cancer cell line PANC-1.
Liu Z; Zhu L; Qin H; Li D; Xie Z; Ke X; Zhao Q
J Huazhong Univ Sci Technolog Med Sci; 2011 Dec; 31(6):762-767. PubMed ID: 22173495
[TBL] [Abstract][Full Text] [Related]
58. CADM1 enhances intestinal barrier function in a rat model of mild inflammatory bowel disease by inhibiting the STAT3 signaling pathway.
Sun S; Liu W; Li Y
J Bioenerg Biomembr; 2020 Oct; 52(5):343-354. PubMed ID: 32929607
[TBL] [Abstract][Full Text] [Related]
59. Increased tumorigenesis associated with loss of the tumor suppressor gene Cadm1.
van der Weyden L; Arends MJ; Rust AG; Poulogiannis G; McIntyre RE; Adams DJ
Mol Cancer; 2012 May; 11():29. PubMed ID: 22553910
[TBL] [Abstract][Full Text] [Related]
60. CADM1 is a key receptor mediating human mast cell adhesion to human lung fibroblasts and airway smooth muscle cells.
Moiseeva EP; Roach KM; Leyland ML; Bradding P
PLoS One; 2013; 8(4):e61579. PubMed ID: 23620770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
